2026 Playbook: Harmonizing Oncology, GLP‑1 Trials for FDA Readiness
A practical 2026 playbook for synchronizing oncology and GLP‑1/tirzepatide programs: regulatory harmonization, risk-based monitoring, and a cost-effectiveness lens to drive FDA inspection readiness.
Robert Maxwell
Oct 06, 2025
breast cancer regulation
Stroke trial approvals
GLP-1 studies
tirzepatide trials
